期刊文献+

The Role of Quality Control in Targeted Next-generation Sequencing Library Preparation 被引量:1

The Role of Quality Control in Targeted Next-generation Sequencing Library Preparation
原文传递
导出
摘要 Next-generation sequencing (NGS) is getting routinely used in the diagnosis of hereditary diseases, such as human cardiomyopathies. Hence. it is of utter importance to secure high quality sequencing data, enabling the identification of disease-relevant mutations or the conclusion of negative test results. During the process of sample preparation, each protocol for target enrichment library preparation has its own requirements for quality control (QC); however, there is little evi- dence on the actual impact of these guidelines on resulting data quality. In this study, we analyzed the impact of QC during the diverse library preparation steps of Agilent SureSelect XT target enrichment and lllumina sequencing. We quantified the parameters for a cohort of around 600 samples, which include starting amount of DNA, amount of sheared DNA, smallest and largest fragment size of the starting DNA; amount of DNA after the pre-PCR, and smallest and largest fragment size of the resulting DNA; as well as the amount of the final library, the corresponding smallest and largest fragment size, and the number of detected variants. Intriguingly, there is a high tolerance for variations in all QC steps, meaning that within the boundaries proposed in the current study, a considerable variance at each step of QC can be well tolerated without compromising NGS quality. Next-generation sequencing (NGS) is getting routinely used in the diagnosis of hereditary diseases, such as human cardiomyopathies. Hence. it is of utter importance to secure high quality sequencing data, enabling the identification of disease-relevant mutations or the conclusion of negative test results. During the process of sample preparation, each protocol for target enrichment library preparation has its own requirements for quality control (QC); however, there is little evi- dence on the actual impact of these guidelines on resulting data quality. In this study, we analyzed the impact of QC during the diverse library preparation steps of Agilent SureSelect XT target enrichment and lllumina sequencing. We quantified the parameters for a cohort of around 600 samples, which include starting amount of DNA, amount of sheared DNA, smallest and largest fragment size of the starting DNA; amount of DNA after the pre-PCR, and smallest and largest fragment size of the resulting DNA; as well as the amount of the final library, the corresponding smallest and largest fragment size, and the number of detected variants. Intriguingly, there is a high tolerance for variations in all QC steps, meaning that within the boundaries proposed in the current study, a considerable variance at each step of QC can be well tolerated without compromising NGS quality.
出处 《Genomics, Proteomics & Bioinformatics》 SCIE CAS CSCD 2016年第4期200-206,共7页 基因组蛋白质组与生物信息学报(英文版)
基金 supported by the German Centre for Cardiovascular Research (DZHK), the European Union (FP7 Inheritance and FP7 Best Ageing), and the German Ministry of Education and Research (BMBF)
关键词 Next-generation sequencing Quality control Library preparation Target enrichment Sequence variants Next-generation sequencing Quality control Library preparation Target enrichment Sequence variants
  • 相关文献

参考文献12

  • 1Smith LM, Sanders JZ, Kaiser R J, Hughes P, Dodd C, Connell CR, et al. Fluorescence detection in automated DNA sequence analysis. Nature 1986;321:674-9.
  • 2Mardis ER. Next-generation sequencing platforms. Annu Rev Anal Chem (Palo Alto Calif) 2013;6:287-303.
  • 3Haas J, Frese KS, Peil B, Kloos W, Keller A, Nietsch R, et al. Atlas of the clinical genetics of human dilated cardiomyopathy. Eur Heart J 2015;36:1123-35.
  • 4Collins FS, Hamburg MA. First FDA authorization for next- generation sequencer. N Engl J Med 2013;369:2369 71.
  • 5Haas J, Barb I, Meder B, Katus HA. Targeted next-generation sequencing: the clinician's stethoscope for genetic disorders. Pers Med 2014;11:581-92.
  • 6Guo Y, Ye F, Sheng Q, Clark T, Samuels DC. Three-stage qualily control strategies for DNA re-sequencing data. Brief Bioinform 2014;15:879-89.
  • 7Ajay SS, Parker SC, Abaan HO, Fajardo KV, Margulies EH. Accurate and comprehensive sequencing of personal genomes. Genome Res 2011;21:1498-505.
  • 8Clark M J, Chen R, Lam HY, Karczewski K J, Chen R, Euskirchen G, et al. Performance comparison of exome DNA sequencing technologies. Nat Biotechnol 2011;29:908-14.
  • 9Sulonen AM, Ellonen P, Almusa H, Lepisto M, Eldfors S, Hannula S, et al. Comparison of solution-based exome capture methods for next generation sequencing. Genome Biol 2011;12: R94.
  • 10Hettmansperger TP, McKean JW. Robust nonparametric statis- tical methods. 2nd ed. UK: Taylor & Francis Group; 2011. p. 74.

同被引文献1

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部